|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.58 USD | +1.74% |
|
+1.54% | -28.46% |
| 07-15 | RxSight Names Aziz Mottiwala as CEO | MT |
| 07-13 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.74% | +1.54% | -11.47% | -3.92% | -28.46% | +38.75% | +137.94% | +126.09% | - | 2.52B | |
| +0.11% | -3.98% | +5.48% | -14.90% | -15.54% | +13.89% | -11.26% | +11.18% | +66.58% | 66.32B | |
| +0.53% | +2.13% | -4.16% | +2.26% | +2.43% | +36.61% | +200.17% | +174.24% | +245.44% | 52.6B | |
| +0.51% | +37.90% | +37.90% | +37.90% | +37.90% | +37.90% | +37.90% | +37.90% | - | 43.27B | |
| -1.32% | -7.38% | -0.67% | -12.14% | -33.84% | -57.63% | -57.10% | -60.98% | -5.49% | 38.64B | |
| +1.46% | -3.97% | +1.74% | +6.78% | +14.00% | +53.17% | -27.51% | -38.35% | -30.29% | 29.62B | |
| +0.78% | +0.03% | +11.77% | +22.23% | +18.14% | +65.07% | +81.90% | +47.15% | +35.04% | 23.31B | |
| -1.81% | -9.71% | -6.52% | +7.89% | +93.35% | +64.46% | -54.90% | -83.65% | - | 22.62B | |
| -1.21% | +1.12% | +15.39% | +4.84% | +17.97% | +1.98% | +170.93% | +17.97% | - | 20.22B | |
| -0.92% | -1.78% | -3.74% | +13.34% | +36.30% | +60.62% | +121.92% | +173.34% | +326.72% | 16.29B | |
| +0.33% | +3.28% | +20.84% | +15.71% | +8.42% | +79.54% | +142.98% | +36.85% | - | 16.26B | |
| -0.04% | -.--% | -.--% | -.--% | -.--% | -.--% | +112.42% | +264.94% | +219.30% | 14.02B | |
| +0.80% | +1.89% | -0.18% | +32.19% | +32.24% | +127.09% | +221.44% | +349.94% | +3,012.50% | 12.43B | |
| +0.03% | -.--% | -.--% | -.--% | +0.96% | +114.68% | +626.02% | +231.15% | - | 11.3B | |
| +0.80% | -1.88% | +4.19% | +9.06% | -0.94% | -1.34% | -32.89% | -23.59% | -37.09% | 11.38B | |
| -2.76% | -4.18% | -3.74% | +22.18% | +32.84% | +113.70% | +172.21% | +440.43% | - | 9.65B | |
| +14.37% | +10.85% | -7.96% | -14.27% | -31.81% | -36.01% | +597.38% | +326.68% | +4,605.33% | 11.13B | |
| +1.54% | +5.05% | +6.07% | +6.55% | -10.88% | -21.84% | -28.22% | -53.98% | -53.51% | 6.46B | |
| -1.88% | +1.33% | +8.75% | +57.08% | +191.42% | +156.56% | +268.14% | -21.22% | - | 5.76B | |
| +1.97% | -12.73% | -1.44% | -18.51% | +8.51% | +19.82% | +261.53% | +235.97% | - | 5.9B | |
| Average | +0.92% | -0.45% | +3.61% | +8.71% | +18.65% | +43.35% | +147.05% | +109.60% | +762.23% | 20.99B | |
| Weighted average by Cap. | +0.57% | -1.52% | +5.96% | +6.15% | +11.54% | +32.55% | +93.93% | +72.86% | +401.67% |
- Stock Market
- Stocks
- TARS Stock
- Sector Tarsus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
